Search results
Results from the WOW.Com Content Network
Pomalidomide, sold under the brand names Pomalyst and Imnovid, [7] [8] is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. [ 7 ] Pomalidomide was approved for medical use in the United States in February 2013, [ 10 ] and in the European Union in August 2013. [ 8 ]
The SPC is not intended to give general advice about treatment of a condition but does state how the product is to be used for a specific treatment. It forms the basis of information for health professionals to know how to use the specific product safely and effectively. The package leaflet supplied with the product is aimed at end-users. [3]
Pomalidomide (3-aminothalidomide) was the second thalidomide analog to enter the clinic being more potent than both of its predecessors. [12] First reported in 2001, pomalidomide was noted to directly inhibit myeloma cell proliferation and thus inhibiting MM both on the tumor and vascular compartments. [ 13 ]
You have a health condition Some medical conditions disrupt metabolic processes, hampering your ability to lose weight in a caloric deficit, says Costa. "These include hypothyroidism , polycystic ...
Body substance isolation is a practice of isolating all body substances (blood, urine, feces, tears, etc.) of individuals undergoing medical treatment, particularly emergency medical treatment of those who might be infected with illnesses such as HIV, or hepatitis so as to reduce as much as possible the chances of transmitting these illnesses. [1]
Jay-Z, the star rapper and entrepreneur whose real name is Shawn Carter, was accused in a lawsuit Sunday of raping a 13-year-old girl in 2000 allegedly along with Sean “Diddy” Combs.
“For years, we always thought it was just willpower, like somebody was overweight because they just couldn’t stop eating,” said Dr. Clayton Runfalo, who practices family medicine at Ochsner ...
In 2009, The National Institute for Health and Clinical Excellence issued a final appraisal determination approving lenalidomide in combination with dexamethasone as an option to treat people with multiple myeloma who have received two or more prior therapies in England and Wales. [19] The use of lenalidomide combined with other drugs was ...